Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination

被引:19
|
作者
Forns, Xavier [1 ,2 ]
Colom, Joan [3 ]
Garcia-Retortillo, Montse [4 ]
Carles Quer, Joan [5 ]
Lens, Sabela [1 ,2 ]
Martro, Elisa [6 ,7 ]
Dominguez-Hernandez, Raquel [8 ]
Angel Casado, Miguel [8 ]
Buti, Maria [2 ,9 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona, Spain
[2] Inst Carlos III, CIBERehd, Barcelona, Spain
[3] Agcy Publ Hlth Catalonia, Programme Prevent Control & Treatment HIV STIs &, Programme Subst Abuse, Barcelona, Spain
[4] Hosp Mar, Dept Gastroenterol, Liver Sect, Barcelona, Spain
[5] Univ Hosp Joan XXIII, Gastroenterol Dept, Tarragona, Spain
[6] Hosp Badalona Germans Trias & Pujol, Inst Invest Ciencies Salut Germans Trias & Pujol, Microbiol Dept, Lab Clin Metropolitana Nord, Badalona, Spain
[7] Inst Salud Carlos III, Biomed Res Networking Ctr Epidemiol & Publ Hlth C, Madrid, Spain
[8] Pharmacoecon & Amp Outcomes Res Iberia PORIB, Madrid, Spain
[9] Hosp Univ Vall dHebron, Internal Med Dept, Liver Unit, Barcelona, Spain
关键词
addiction centres; cascade of care; drug users; harm reduction services; hepatitis C virus; linkage-to-care; test and treat;
D O I
10.1111/jvh.13634
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
According to WHO goals, the elimination of Hepatitis C Virus (HCV) by 2030 requires enhancing and simplifying HCV testing. Our aim was to create a model to assess and compare different strategies for HCV testing, linkage to care and treatment among people who access harm reduction centres (HRC) and Addiction Centres in Catalonia. A decision tree model was designed to evaluate two strategies: Hepatitis C Point-of-care (POC) "test and treat", at the community versus standard-of-care (SOC), in which HCV testing was performed at community and therapy at the hospital. Both strategies were assessed separately in HRCs (6,878 users) and Addiction Centres (13,778 users). with a time horizon of 18 months. Healthcare outcomes were HCV testing, linkage to care, treatment outcomes and reinfection rate. HCV testing was performed in 3,178 (46%) of the HRC users. Compared with SOC, POC increased access to treatment by 57% (63% vs. 6%). SVR rates were 64% in POC vs. 23% in SOC. Reinfection rates were 21% with POC compared to 24% with SOC. With POC, losses to follow-up were reduced by 41%. In the Addiction Centres, 12,566 users (91%) were screened using the two strategies. Compared to the SOC, POC increased access to treatment and linkage to care by 19% along with SVR at the same rate. Reinfection rates decreased by 6%. Thus, the implementation of a POC "test and treat" strategy at HRCs and Addiction Centres has shown to be an effective public health strategy to help eliminating HCV in accordance with WHO goal.
引用
收藏
页码:227 / 230
页数:4
相关论文
共 50 条
  • [1] Real-World Evaluation of Point-of-Care Testing for Hepatitis C Antibodies: Navigating Hepatitis C Elimination Effort
    Yew, Kuo Chao
    Sim, Alyssa Shin Yee
    Hawkins, Robert
    Acharyya, Sanchalika
    Wong, Gerard Daquan
    Wong, Samuel Wei Chong
    Lim, Yuan Heng
    Yang, Wei Lyn
    Lim, Wei-Yen
    Chow, Angela Li Ping
    JOURNAL OF VIRAL HEPATITIS, 2025, 32 (04)
  • [2] Certification program of Addiction Centres for hepatitis C virus elimination in Spain. HepCelentes Project
    Colom, Joan
    Torrens, Marta
    Rodriguez-Cejas, Angeles
    Aguilar, Ignacio
    Alvarez-Crespo, Rocio
    Armenteros, Lorenzo
    Ayala, Victoria
    Cantero, Helena
    Casado, Miguel Angel
    Crespo, Javier
    Estevez, Joaquin
    Garcia-Samaniego, Javier
    Hernandez-Guerra, Manuel
    Mur, Carlos
    Perez-Bech, Eva
    Ricote, Mercedes
    Pineda, Juan Antonio
    ADICCIONES, 2024, 36 (02)
  • [3] Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility
    Macisaac, Mb
    Whitton, B.
    Anderson, J.
    Cogger, S.
    Vella-Horne, D.
    Penn, M.
    Weeks, T.
    Elmore, K.
    Pemberton, D.
    Winter, Rj
    Papaluca, T.
    Howell, J.
    Hellard, M.
    Stoove, M.
    Wilson, D.
    Pedrana, A.
    Doyle, Js
    Clark, N.
    Holmes, Ja
    Thompson, Aj
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2024, 125
  • [4] Point-of-Care Testing for Hepatitis Viruses: A Growing Need
    Pauly, Matthew D.
    Ganova-Raeva, Lilia
    LIFE-BASEL, 2023, 13 (12):
  • [5] Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
    Pericas, Juan M.
    Bromberg, Daniel J.
    Ocampo, Denise
    Schatz, Eberhard
    Wawer, Iwona
    Wysocki, Piotr
    Safreed-Harmon, Kelly
    Lazarus, Jeffrey V.
    HARM REDUCTION JOURNAL, 2019, 16 (1)
  • [6] Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal
    Burgui, Cristina
    San Miguel, Ramon
    Goni-Esarte, Silvia
    Juanbeltz, Regina
    Isidro Uriz-Otano, Juan
    Reparaz, Jesus
    Sarobe, Maite
    Manuel Zozaya, Jose
    Castilla, Jesus
    POSTGRADUATE MEDICINE, 2023, 135 (04) : 352 - 360
  • [7] Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
    Juan M. Pericàs
    Daniel J. Bromberg
    Denise Ocampo
    Eberhard Schatz
    Iwona Wawer
    Piotr Wysocki
    Kelly Safreed-Harmon
    Jeffrey V. Lazarus
    Harm Reduction Journal, 16
  • [8] Strategies for Hepatitis C Testing and Linkage to Care for Vulnerable Populations: Point-of-Care and Standard HCV Testing in a Mobile Medical Clinic
    Morano, Jamie P.
    Zelenev, Alexei
    Lombard, Andrea
    Marcus, Ruthanne
    Gibson, Britton A.
    Altice, Frederick L.
    JOURNAL OF COMMUNITY HEALTH, 2014, 39 (05) : 922 - 934
  • [9] Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
    Iversen, Jenny
    Grebely, Jason
    Catlett, Beth
    Cunningham, Philip
    Dore, Gregory J.
    Maher, Lisa
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 : 77 - 85
  • [10] Hepatitis C antibody prevalence and behavioral correlates in people who inject drugs attending harm reduction services in Lisbon, Portugal
    Curado, Adriana
    Nogueira, Paulo Jorge
    Virgolino, Ana
    Santa Maria, Joo
    Mendao, Luis
    Furtado, Cristina
    Antunes, Francisco
    FRONTIERS IN PUBLIC HEALTH, 2022, 10